
    
      The APERTO CVS PMCF study is aimed to evaluate safety and effectiveness of treatment of
      central veins (re)stenosis in dialysis patients at short and mid-term follow up, after
      treatment with APERTO OTW DCB. Primary endpoint will consist in evaluating the intervention
      free period for patients treated with APERTO OTW.

      APERTO CVS PMCF Study will also collect data for post-market clinical follow up (PMCF) in a
      CE mark device used according to intended use
    
  